The Brazilian private pharmaceutical market after the first ten years of the generics law
Objectives To describe changes in the private market for selected originators, branded generics (‘similares’), and generic products during the 10 years following passage of the Brazilian Generics Law. Methods We analyzed longitudinal data collected by IQVIA® on quarterly sales by wholesalers to reta...
Main Authors: | Andréa Dâmaso Bertoldi, Anita K. Wagner, Isabel Cristina Martins Emmerick, Luisa Arueira Chaves, Peter Stephens, Dennis Ross-Degnan |
---|---|
Format: | Article |
Language: | English |
Published: |
Taylor & Francis Group
2019-12-01
|
Series: | Journal of Pharmaceutical Policy and Practice |
Subjects: | |
Online Access: | http://dx.doi.org/10.1186/s40545-019-0179-9 |
Similar Items
-
Brazilian generics market change after Farmácia Popular program
by: Andréa Dâmaso Bertoldi, et al.
Published: (2019-10-01) -
A comparison of generic drug prices in seven European countries: a methodological analysis
by: Olivier J. Wouters, et al.
Published: (2017-03-01) -
Generic Medicine Pricing Policies in Europe: Current Status and Impact
by: Pieter Dylst, et al.
Published: (2010-03-01) -
Which factor reduces pharmaceutical expenditure, number of entrants or price variance? Updated generic drug markets in South Korea
by: Kyung-Bok Son
Published: (2024-08-01) -
Is Brand Name Best? Brand name versus generic pharmaceuticals in clinical practice
by: Andrea Bakker
Published: (2017-06-01)